Complete Exam Guide Subject-wise practice platform
Clinical Pharmacology

Clinical Trials Practice Questions

20 free Clinical Trials practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Clinical Trials questions

20 questions
  1. Q1. Which phase of a clinical trial is primarily designed to determine the Maximum Tolerated Dose (MTD) and evaluate the safety profile in a small group of healthy…
  2. Q2. A Phase II clinical trial is best described by which of the following characteristics?
  3. Q3. What is the primary objective of a Phase III clinical trial?
  4. Q4. Which term refers to a clinical trial design where neither the investigator nor the participant knows which treatment is being administered?
  5. Q5. Phase IV clinical trials are also known as:
  6. Q6. In a 'Crossover' study design, what happens to the participants?
  7. Q7. What is the purpose of an 'Orphan Drug' designation?
  8. Q8. An 'Intent-to-Treat' (ITT) analysis is used in clinical trials to:
  9. Q9. Which regulatory document must be submitted to the FDA before a drug can begin Phase I human testing?
  10. Q10. What does the term 'Placebo Effect' refer to in the context of clinical trials?
  11. Q11. A 'Single-Blind' study is most commonly used when:
  12. Q12. Which of the following is an example of a 'Surrogate Endpoint' in a clinical trial?
  13. Q13. In the context of drug development, what is a 'Lead Compound'?
  14. Q14. Which organization is responsible for ensuring the ethical conduct of a clinical trial at a specific hospital or university?
  15. Q15. A trial designed to show that a new drug is 'no worse than' the current standard of care is called a:
  16. Q16. The 'Nuremberg Code' and 'Declaration of Helsinki' are fundamental documents relating to:
  17. Q17. Which phase of clinical testing is often skipped or shortened for 'Breakthrough Therapies' for life-threatening conditions?
  18. Q18. What is the primary focus of 'Pharmacovigilance'?
  19. Q19. In clinical trials, 'Randomization' is primarily used to:
  20. Q20. Which document is signed by a participant to indicate they understand the risks and benefits of a study?